×

IPCI – intellipharmaceutics (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day IPCI SPY QQQ SPX
Date Time Symbol Headline Impact
8/22 10:35 am ipci SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) & Lead Plaintiff Deadline: September 29, 2017 Medium
8/18 10:50 pm ipci INTELLIPHARMACEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against IntelliPharmaCeutics International, Inc. - ( Low
8/17 05:13 pm ipci IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm Medium
8/17 11:25 am ipci SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. and Set Lead Plaintiff Deadline of September 29, 2017 -- IPCI Medium
8/15 04:19 pm ipci IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm High
8/15 10:35 am ipci SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) & Lead Plaintiff Deadline: September 29, 2017 High
8/14 11:08 am ipci The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Intellipharmaceutics International Inc. Shareholders and a Lead Plaintiff Deadline of September 29, 2017 Medium
8/11 02:09 pm ipci LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In IntelliPharmaCeutics International Inc. To Contact The Firm Medium
8/10 02:12 pm ipci INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm Low
8/9 12:48 pm ipci IPCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Intellipharmaceutics International Inc. and a Lead Plaintiff Deadline of September 29, 2017 Low
8/8 03:00 pm ipci Intellipharmaceutics Announces Resignation of Chief Financial Officer Neutral
8/7 02:25 pm ipci Robbins Arroyo LLP: IntelliPharmaCeutics International Inc. (IPCI) Misled Shareholders According to a Recently Filed Class Action Medium
8/4 01:47 pm ipci The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Intellipharmaceutics International Inc. (IPCI) Low
8/3 01:37 pm ipci IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm Low
8/2 01:30 pm ipci SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) & Lead Plaintiff Deadline: September 29, 2017 Medium
8/1 11:38 am ipci IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm Low
7/31 02:48 pm ipci SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. Low
7/27 04:14 pm ipci Intellipharmaceutics International Inc. (NASDAQ: IPCI) had its price target lowered by analysts at Maxim Group from $6.00 to $2.00. They now have a "buy" rating on the stock. Medium
7/27 07:08 am ipci Intellipharmaceutics to conduct new HAP study to support abuse-deterrent claim for Rexista [Seeking Alpha] High
7/25 11:33 am ipci IntelliPharmaCeutics International - Very Low Downside And Huge Upside [Seeking Alpha] Medium
7/21 04:13 pm ipci Intellipharmaceutics International Inc. (NASDAQ: IPCI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $6.00 price target on the stock. High
7/14 02:27 am ipci Intellipharmaceutics International Inc. (NASDAQ: IPCI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. Low
7/11 05:15 pm ipci Intellipharmaceutics Announces Second Quarter 2017 Results Medium
7/11 03:50 pm ipci Intellipharmaceutics follows through on Ad Com-stoked up move, shares ahead 18% [Seeking Alpha] Low
7/5 02:07 am ipci Intellipharmaceutics International Inc. (NASDAQ: IPCI) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. Medium
6/30 04:05 pm ipci Intellipharmaceutics Announces FDA Advisory Committee Meeting for Rexista™ (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain High
6/30 01:14 pm ipci Intellipharmaceutics International Inc. (NASDAQ: IPCI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $6.00 price target on the stock. Low
6/7 02:23 pm ipci IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. Low
6/6 08:50 am ipci Intellipharmaceutics Announces Launch of Generic Seroquel XR® by Mallinckrodt Medium
5/30 07:10 am ipci Intellipharmaceutics files new F-3 for $100M shelf offering [Seeking Alpha] Low
5/26 03:00 pm ipci IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. Low
5/24 04:05 pm ipci Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical Low
5/11 02:49 pm ipci IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. Neutral
5/10 03:18 pm ipci Intellipharmaceutics Announces FDA Final Approval of Generic Seroquel XR® Low
4/18 07:28 pm ipci Intellipharmaceutics Reports Director Election Results [Canadian Business Journal (Canada)] Low
4/18 11:52 am ipci IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $6.00 price target on the stock. Neutral
4/12 05:45 am ipci IntelliPharmaCeutics EPS in-line, misses on revenue [Seeking Alpha] Medium
4/10 08:00 am ipci Intellipharmaceutics Announces Patent Litigation by Purdue against its Rexista™ Abuse-Deterrent Extended-Release Oxycodone Medium
3/29 08:15 am ipci Research Reports Initiated on Healthcare Stocks BELLUS Health, Resverlogix, Helius Medical Technologies, and IntelliPharmaCeutics International Medium
3/22 12:44 am ipci IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. Low
3/17 12:30 pm ipci IntelliPharmaCeutics International: Great Opportunity, But Not Right Now [Seeking Alpha] Low
3/16 08:00 am ipci Intellipharmaceutics Announces TSX Trading Symbol Change to “IPCI” Neutral
2/24 08:00 am ipci Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR Medium
2/10 08:00 am ipci Intellipharmaceutics Announces 2016 Year End Results Medium
2/2 05:00 pm ipci Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista™ (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain Low
1/12 11:50 am ipci IntelliPharmaCeutics Intl (IPCI) Presents At 9th Annual Biotech Showcase 2017 Conference [Seeking Alpha] Low
1/9 08:16 am ipci Intellipharmaceutics International Inc. (NASDAQ: IPCI) had its "buy" rating re-affirmed by analysts at Aegis. They now have a $8.00 price target on the stock. Medium
1/6 08:00 am ipci Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical Low
1/3 09:05 am ipci 4 Catalyst-Driven Stocks For Your 2017 Portfolio [Seeking Alpha] Low
12/29 09:28 am ipci Intellipharmaceutics to Present at the Biotech Showcase™ [Canadian Business Journal (Canada)] Low
Date Time Symbol Company Name Action %Chg
4/11 06:48 pm IPCI intellipharmaceutics BEAT 5.4%
10/13 11:00 pm IPCI intellipharmaceutics IN-LINE -1.4%
Date Time Action From To Firm Impact %CHG DETAILS
8/15 02:38 am Upgrades Sell Hold Zacks Investment Research High 28.3%
7/28 02:03 am Downgrades Hold Sell ValuEngine Medium 3.7%
7/21 04:13 pm Reiterates Buy Maxim Group High -10.0%
7/14 02:27 am Downgrades Hold Sell Zacks Investment Research Low -1.1%
7/5 02:07 am Downgrades Buy Hold Zacks Investment Research Medium -4.0%
6/30 01:14 pm Reiterates Buy Maxim Group Low 1.0%
5/26 03:00 pm Upgrades Sell Hold ValuEngine Low 0.5%
5/25 08:11 am Reiterates Buy Maxim Group Low -2.5%
4/18 11:52 am Reiterates Buy Maxim Group 0.0%
4/12 03:54 am Downgrades Buy Hold Aegis Medium 5.4%
3/22 12:44 am Upgrades Sell Hold Zacks Investment Research Low -2.2%
1/9 08:16 am Reiterates Buy Aegis Medium -3.2%
1/6 01:23 am Upgrades Sell Hold Zacks Investment Research Low -2.6%
12/28 12:38 am Upgrades Sell Hold Zacks Investment Research Medium -4.4%
12/14 12:47 am Upgrades Sell Hold Zacks Investment Research Low -1.8%
12/2 11:49 am Downgrades Hold Sell Zacks Investment Research Low -1.1%
11/29 12:03 pm Reiterates Buy Aegis Low -2.8%
10/27 11:44 pm Downgrades Buy Hold Zacks Investment Research Low 0.3%
10/21 08:40 pm Reiterates Buy Maxim Group Medium -3.2%
10/18 11:44 pm Upgrades Sell Buy Zacks Investment Research Medium 7.9%
10/13 11:03 pm Downgrades Hold Sell Zacks Investment Research Low -1.4%
10/4 06:13 am Initiates BUY BREAN CAPITAL Medium -4.9%
10/3 10:44 am Initiates Buy Brean Capital Medium 6.5%
9/14 11:38 pm Downgrades Buy Hold Zacks Investment Research Medium 4.0%
9/13 11:23 pm Upgrades Hold Buy Zacks Investment Research Low -1.1%
Date Time Symbol Headline Impact
8/8 03:05 pm ipci Form 6-K Intellipharmaceutics For: Aug 04 Low
7/31 08:09 am ipci Form 6-K Intellipharmaceutics For: Jul 31 Medium
7/27 06:07 am ipci Form 6-K Intellipharmaceutics For: Jul 26 High
7/18 05:15 pm ipci Form 424B5 Intellipharmaceutics Low
7/18 06:05 am ipci Form 424B3 Intellipharmaceutics Low
7/14 05:28 pm ipci Form F-3/A Intellipharmaceutics Medium
7/11 05:27 pm ipci Form 6-K Intellipharmaceutics For: May 31 Medium
7/11 06:06 am ipci Form F-3/A Intellipharmaceutics High
6/30 04:12 pm ipci Form 6-K Intellipharmaceutics For: Jun 30 Medium
6/6 08:54 am ipci Form 6-K Intellipharmaceutics For: Jun 06 Medium
5/30 06:05 am ipci Form 6-K Intellipharmaceutics For: May 26 Low
5/24 04:15 pm ipci Form 6-K Intellipharmaceutics For: May 24 Low
5/10 03:21 pm ipci Form 6-K Intellipharmaceutics For: May 03 Low
4/19 06:04 am ipci Form 6-K Intellipharmaceutics For: Apr 18 Low
4/12 06:05 am ipci Form 6-K Intellipharmaceutics For: Feb 28 Medium
4/10 08:04 am ipci Form 6-K Intellipharmaceutics For: Apr 10 Medium
4/4 10:52 am ipci Form CT ORDER Intellipharmaceutics Low
3/21 06:06 am ipci Form 6-K Intellipharmaceutics For: Mar 20 Medium
3/16 08:09 am ipci Form 6-K Intellipharmaceutics For: Mar 16 Neutral
2/28 05:01 pm ipci Form 6-K Intellipharmaceutics For: Feb 27 Medium
2/24 08:06 am ipci Form 6-K Intellipharmaceutics For: Feb 24 Medium
2/10 08:08 am ipci Form 6-K Intellipharmaceutics For: Nov 30 Medium
2/2 05:04 pm ipci Form 6-K Intellipharmaceutics For: Feb 02 Medium
1/6 08:16 am ipci Form 6-K Intellipharmaceutics For: Jan 05 Low
12/29 08:02 am ipci Form 6-K Intellipharmaceutics For: Dec 29 Low
12/21 08:08 am ipci Form 6-K Intellipharmaceutics For: Dec 21 Medium
11/29 08:06 am ipci Form 6-K Intellipharmaceutics For: Nov 29 Medium
11/25 07:50 am ipci Form 6-K Intellipharmaceutics For: Nov 23 Low
10/14 09:04 am ipci Form 6-K Intellipharmaceutics For: Oct 14 Low
10/11 05:07 pm ipci Form 6-K Intellipharmaceutics For: Oct 11 Medium
10/11 06:09 am ipci Form 6-K Intellipharmaceutics For: Oct 07 High
10/6 04:52 pm ipci Form 6-K Intellipharmaceutics For: Oct 06 Medium
9/22 04:10 pm ipci Form 6-K Intellipharmaceutics For: Sep 22 Medium
9/13 02:06 pm ipci Form 6-K Intellipharmaceutics For: Sep 13 Medium
8/25 04:00 pm ipci Form 6-K Intellipharmaceutics For: Aug 25 Low
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.